NEUROCRINE BIOSCIENCES INC Increase (Decrease) in Accounts Payable and Accrued Liabilities
NEUROCRINE BIOSCIENCES INC (NBIX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$22.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-31
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$8.50M, a 156.29% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$14.30M.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $76.50M, a 1.03% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $71.60M, a 61.99% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $160.20M, a 269.12% increase from fiscal 2024.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $43.40M, a 11.43% decline from fiscal 2023.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $49.00M, a 57.24% decline from fiscal 2022.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $114.60M, a 101.76% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$22.80M 10-Q · filed 2026-07-31 | $53.70M derived: sum of 3 quarters · filed 2026-07-31 | $125.30M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | -$14.30M 10-Q · filed 2026-05-05 | $62.20M derived: sum of 2 quarters · filed 2026-05-05 | $133.80M derived: sum of 3 quarters · filed 2026-05-05 | $148.90M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $76.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $148.10M derived: sum of 2 quarters · filed 2026-02-11 | $163.20M derived: sum of 3 quarters · filed 2026-07-31 | $160.20M 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | $71.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $86.70M derived: sum of 2 quarters · filed 2026-07-31 | $83.70M 10-Q · filed 2025-10-28 | $161.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | $15.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $12.10M 10-Q · filed 2026-07-31 | $27.90M 10-Q · filed 2025-07-30 | $89.40M derived: sum of 3 quarters · filed 2026-07-31 | $133.60M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-03-31 | -$3.00M 10-Q · filed 2026-05-05 | $12.40M 10-Q · filed 2025-05-05 | $74.30M derived: sum of 2 quarters · filed 2026-05-05 | $118.50M derived: sum of 3 quarters · filed 2026-05-05 | $59.00M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $77.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $121.50M derived: sum of 2 quarters · filed 2026-02-11 | $62.00M derived: sum of 3 quarters · filed 2026-02-11 | $43.40M 10-K · filed 2026-02-11 | $29.00M 10-K · filed 2025-02-10 | |||
| 2024-09-30 | $44.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$15.30M derived: sum of 2 quarters · filed 2025-10-28 | -$33.90M 10-Q · filed 2025-10-28 | -$38.70M 10-Q · filed 2024-10-30 | -$132.20M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-06-30 | -$59.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$78.10M 10-Q · filed 2025-07-30 | -$176.40M derived: sum of 3 quarters · filed 2026-02-11 | -$52.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | -$18.60M 10-Q · filed 2025-05-05 | -$116.90M derived: sum of 2 quarters · filed 2026-02-11 | $7.50M derived: sum of 3 quarters · filed 2026-02-11 | $23.70M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | -$98.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $26.10M derived: sum of 2 quarters · filed 2026-02-11 | $42.30M derived: sum of 3 quarters · filed 2026-02-11 | $49.00M 10-K · filed 2026-02-11 | $64.30M 10-K · filed 2024-02-09 | |||
| 2023-09-30 | $124.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $140.60M derived: sum of 2 quarters · filed 2024-10-30 | $147.30M 10-Q · filed 2024-10-30 | $184.90M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $16.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $22.90M 10-Q · filed 2024-08-01 | $60.50M derived: sum of 3 quarters · filed 2025-02-10 | $93.30M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $6.70M 10-Q · filed 2024-05-01 | $44.30M derived: sum of 2 quarters · filed 2025-02-10 | $77.10M derived: sum of 3 quarters · filed 2025-02-10 | $109.80M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | $37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $70.40M derived: sum of 2 quarters · filed 2025-02-10 | $103.10M derived: sum of 3 quarters · filed 2025-02-10 | $114.60M 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | $32.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $65.50M derived: sum of 2 quarters · filed 2023-10-31 | $77.00M 10-Q · filed 2023-10-31 | $96.10M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-06-30 | $32.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $44.20M 10-Q · filed 2023-08-01 | $63.30M derived: sum of 3 quarters · filed 2024-02-09 | $72.00M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-03-31 | $11.50M 10-Q · filed 2023-05-03 | $30.60M derived: sum of 2 quarters · filed 2024-02-09 | $39.30M derived: sum of 3 quarters · filed 2024-02-09 | $57.30M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2021-12-31 | $19.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $27.80M derived: sum of 2 quarters · filed 2024-02-09 | $45.80M derived: sum of 3 quarters · filed 2024-02-09 | $56.80M 10-K · filed 2024-02-09 | ||||
| 2021-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $26.70M derived: sum of 2 quarters · filed 2022-11-01 | $37.70M 10-Q · filed 2022-11-01 | $36.50M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $29.00M 10-Q · filed 2022-08-04 | $27.80M derived: sum of 3 quarters · filed 2023-02-09 | $61.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $11.00M 10-Q · filed 2022-05-04 | $9.80M derived: sum of 2 quarters · filed 2023-02-09 | $43.00M derived: sum of 3 quarters · filed 2023-02-09 | $54.10M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $32.00M derived: sum of 2 quarters · filed 2023-02-09 | $43.10M derived: sum of 3 quarters · filed 2023-02-09 | $26.90M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $33.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $44.30M derived: sum of 2 quarters · filed 2021-11-01 | $28.10M 10-Q · filed 2021-11-01 | $69.80M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $11.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$5.10M 10-Q · filed 2021-08-03 | $36.60M derived: sum of 3 quarters · filed 2022-02-11 | $41.20M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | -$16.20M 10-Q · filed 2021-05-05 | $25.50M derived: sum of 2 quarters · filed 2022-02-11 | $30.10M derived: sum of 3 quarters · filed 2022-02-11 | $54.40M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $41.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $46.30M derived: sum of 2 quarters · filed 2022-02-11 | $70.60M derived: sum of 3 quarters · filed 2022-02-11 | $54.00M 10-K · filed 2022-02-11 | $53.95M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $28.90M derived: sum of 2 quarters · filed 2020-11-09 | $12.30M 10-Q · filed 2020-11-09 | $12.34M 10-Q · filed 2019-11-04 | $20.92M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-06-30 | $24.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $7.70M 10-Q · filed 2020-08-03 | $7.74M 10-Q · filed 2019-07-29 | $16.32M derived: sum of 3 quarters · filed 2021-02-05 | $27.63M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-03-31 | -$16.60M 10-Q · filed 2020-05-06 | -$16.57M 10-Q · filed 2019-04-29 | -$7.98M derived: sum of 2 quarters · filed 2021-02-05 | $3.33M derived: sum of 3 quarters · filed 2021-02-05 | $15.47M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2018-12-31 | $8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-05 | $19.93M derived: sum of 2 quarters · filed 2021-02-05 | $32.07M derived: sum of 3 quarters · filed 2021-02-05 | $24.20M 10-K · filed 2021-02-05 | $24.22M 10-K · filed 2019-02-08 | |||
| 2018-09-30 | $11.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $23.45M derived: sum of 2 quarters · filed 2019-11-04 | $15.58M 10-Q · filed 2019-11-04 | $31.81M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $12.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $4.27M 10-Q · filed 2019-07-29 | $20.50M derived: sum of 3 quarters · filed 2020-02-07 | $30.98M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | -$7.87M 10-Q · filed 2019-04-29 | $8.36M derived: sum of 2 quarters · filed 2020-02-07 | $18.84M derived: sum of 3 quarters · filed 2020-02-07 | $26.39M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2017-12-31 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $26.71M derived: sum of 2 quarters · filed 2020-02-07 | $34.27M derived: sum of 3 quarters · filed 2020-02-07 | $27.34M 10-K · filed 2020-02-07 | ||||
| 2017-09-30 | $10.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $18.03M derived: sum of 2 quarters · filed 2018-11-05 | $11.11M 10-Q · filed 2018-11-05 | $14.63M derived: sum of 4 quarters · filed 2019-02-08 | ||||
| 2017-06-30 | $7.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $627.00K 10-Q · filed 2018-07-31 | $4.15M derived: sum of 3 quarters · filed 2019-02-08 | $3.84M derived: sum of 4 quarters · filed 2019-02-08 | ||||
| 2017-03-31 | -$6.93M 10-Q · filed 2018-04-30 | -$3.41M derived: sum of 2 quarters · filed 2019-02-08 | -$3.71M derived: sum of 3 quarters · filed 2019-02-08 | -$182.00K derived: sum of 4 quarters · filed 2019-02-08 | ||||
| 2016-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | $3.21M derived: sum of 2 quarters · filed 2019-02-08 | $6.75M derived: sum of 3 quarters · filed 2019-02-08 | $4.40M 10-K · filed 2019-02-08 | ||||
| 2016-09-30 | -$306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $3.23M derived: sum of 2 quarters · filed 2017-11-01 | $878.00K 10-Q · filed 2017-11-01 | $6.76M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.18M 10-Q · filed 2017-08-03 | $7.07M derived: sum of 3 quarters · filed 2018-02-13 | $9.35M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-31 | -$2.35M 10-Q · filed 2017-05-09 | $3.54M derived: sum of 2 quarters · filed 2018-02-13 | $5.82M derived: sum of 3 quarters · filed 2018-02-13 | $8.04M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2015-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $8.17M derived: sum of 2 quarters · filed 2018-02-13 | $10.39M derived: sum of 3 quarters · filed 2018-02-13 | $9.84M 10-K · filed 2018-02-13 | ||||
| 2015-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $4.50M derived: sum of 2 quarters · filed 2016-11-02 | $3.96M 10-Q · filed 2016-11-02 | $5.50M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.67M 10-Q · filed 2016-08-03 | $3.22M derived: sum of 3 quarters · filed 2017-02-14 | $5.14M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-31 | -$546.00K 10-Q · filed 2016-05-05 | $1.00M derived: sum of 2 quarters · filed 2017-02-14 | $2.92M derived: sum of 3 quarters · filed 2017-02-14 | $4.28M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $3.47M derived: sum of 2 quarters · filed 2017-02-14 | $4.83M derived: sum of 3 quarters · filed 2017-02-14 | $3.70M 10-K · filed 2017-02-14 | ||||
| 2014-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $3.28M derived: sum of 2 quarters · filed 2015-10-29 | $2.15M 10-Q · filed 2015-10-29 | $1.23M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $229.00K 10-Q · filed 2015-07-29 | -$694.00K derived: sum of 3 quarters · filed 2016-02-11 | -$1.25M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | -$1.13M 10-Q · filed 2015-04-30 | -$2.05M derived: sum of 2 quarters · filed 2016-02-11 | -$2.60M derived: sum of 3 quarters · filed 2016-02-11 | -$1.11M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | -$923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$1.48M derived: sum of 2 quarters · filed 2016-02-11 | $19.00K derived: sum of 3 quarters · filed 2016-02-11 | -$949.00K 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | -$554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $942.00K derived: sum of 2 quarters · filed 2014-11-04 | -$26.00K 10-Q · filed 2014-11-04 | -$567.00K derived: sum of 4 quarters · filed 2015-02-09 | ||||
| 2013-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $528.00K 10-Q · filed 2014-08-06 | -$13.00K derived: sum of 3 quarters · filed 2015-02-09 | $1.18M derived: sum of 4 quarters · filed 2015-02-09 | ||||
| 2013-03-31 | -$968.00K 10-Q · filed 2014-05-01 | -$1.51M derived: sum of 2 quarters · filed 2015-02-09 | -$320.00K derived: sum of 3 quarters · filed 2015-02-09 | $474.00K derived: sum of 4 quarters · filed 2015-02-09 | ||||
| 2012-12-31 | -$541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | $648.00K derived: sum of 2 quarters · filed 2015-02-09 | $1.44M derived: sum of 3 quarters · filed 2015-02-09 | -$557.00K 10-K · filed 2015-02-09 | ||||
| 2012-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $1.98M derived: sum of 2 quarters · filed 2013-10-29 | -$16.00K 10-Q · filed 2013-10-29 | $1.22M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $794.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$1.21M 10-Q · filed 2013-07-26 | $29.00K derived: sum of 3 quarters · filed 2014-02-11 | $111.00K derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | -$2.00M 10-Q · filed 2013-05-02 | -$765.00K derived: sum of 2 quarters · filed 2014-02-11 | -$683.00K derived: sum of 3 quarters · filed 2014-02-11 | $1.17M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $1.32M derived: sum of 2 quarters · filed 2014-02-11 | $3.17M derived: sum of 3 quarters · filed 2014-02-11 | $149.00K 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $1.93M derived: sum of 2 quarters · filed 2012-10-31 | -$1.08M 10-Q · filed 2012-10-31 | -$918.00K derived: sum of 4 quarters · filed 2013-02-08 | ||||
| 2011-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | -$1.17M 10-Q · filed 2012-07-31 | -$1.00M derived: sum of 3 quarters · filed 2013-02-08 | $434.00K derived: sum of 4 quarters · filed 2013-02-08 | ||||
| 2011-03-31 | -$3.02M 10-Q · filed 2012-05-02 | -$2.85M derived: sum of 2 quarters · filed 2013-02-08 | -$1.42M derived: sum of 3 quarters · filed 2013-02-08 | |||||
| 2010-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $1.60M derived: sum of 2 quarters · filed 2013-02-08 | $985.00K 10-K · filed 2013-02-08 | |||||
| 2010-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $818.00K 10-Q · filed 2011-10-31 | ||||||
| 2010-06-30 | -$616.00K 10-Q · filed 2011-07-29 | |||||||
| 2009-12-31 | -$4.08M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |